New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
COVID vaccine induces robust T cell responses in blood cancer patients

COVID vaccine induces robust T cell responses in blood cancer patients

by The Peter Doherty Institute for Infection and ImmunityGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101017Researchers have found that, despite being h
Public Health & Prevention April 12,2024
COVID vaccine induces robust T cell responses in blood cancer patients

COVID vaccine induces robust T cell responses in blood cancer patients

by The Peter Doherty Institute for Infection and ImmunityGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101017Researchers have found that, despite being h
Public Health & Prevention April 12,2024
CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

by Perelman School of Medicine at the University of PennsylvaniaGraphic showing genetic alternations of cells tested in trial. Credit: Joseph Fraietta, PhD, University of PennsylvaniaGenetically-
Oncology April 12,2024
CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

CRISPR-edited immune cells can survive and thrive after infusion into cancer patients

by Perelman School of Medicine at the University of PennsylvaniaGraphic showing genetic alternations of cells tested in trial. Credit: Joseph Fraietta, PhD, University of PennsylvaniaGenetically-
Oncology April 12,2024
Effectiveness of COVID vaccines unclear for people with immune deficiencies—but they're safe and worthwhile

Effectiveness of COVID vaccines unclear for people with immune deficiencies—but they're safe and worthwhile

by Vanessa Bryant and Charlotte Slade,The ConversationCredit: AI-generated imageThe COVID vaccine rollout is underway in Australia, with people inphase 1bnow eligible to be vaccinate
Public Health & Prevention April 12,2024
Effectiveness of COVID vaccines unclear for people with immune deficiencies—but they're safe and worthwhile

Effectiveness of COVID vaccines unclear for people with immune deficiencies—but they're safe and worthwhile

by Vanessa Bryant and Charlotte Slade,The ConversationCredit: AI-generated imageThe COVID vaccine rollout is underway in Australia, with people inphase 1bnow eligible to be vaccinate
Public Health & Prevention April 12,2024
CRISPR screen identifies new anti-inflammatory drug target

CRISPR screen identifies new anti-inflammatory drug target

by Vanderbilt University Medical CenterCredit: CC0 Public DomainA metabolic enzyme that has been studied in cancer biology and is important for T cell function may offer a new target for anti-inf
Immunology & Rheumatology April 12,2024
CRISPR screen identifies new anti-inflammatory drug target

CRISPR screen identifies new anti-inflammatory drug target

by Vanderbilt University Medical CenterCredit: CC0 Public DomainA metabolic enzyme that has been studied in cancer biology and is important for T cell function may offer a new target for anti-inf
Immunology & Rheumatology April 12,2024
CRISPR-edited CAR T cells enhance fight against blood cancers

CRISPR-edited CAR T cells enhance fight against blood cancers

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainKnocking out a protein known to stifle T cell activation on CAR T cells using the CRISPR/Cas9 technology e
Oncology April 12,2024
CRISPR-edited CAR T cells enhance fight against blood cancers

CRISPR-edited CAR T cells enhance fight against blood cancers

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainKnocking out a protein known to stifle T cell activation on CAR T cells using the CRISPR/Cas9 technology e
Oncology April 12,2024
Are autoantibodies in COVID-19 less harmful than previously thought?

Are autoantibodies in COVID-19 less harmful than previously thought?

by Berlin Institute of Health in der Charité (BIH)3D model of an antibody. Credit: TokenzeroCritically ill COVID-19 patients often have antibodies in their blood that bind to the body's own struct
Public Health & Prevention April 12,2024
Are autoantibodies in COVID-19 less harmful than previously thought?

Are autoantibodies in COVID-19 less harmful than previously thought?

by Berlin Institute of Health in der Charité (BIH)3D model of an antibody. Credit: TokenzeroCritically ill COVID-19 patients often have antibodies in their blood that bind to the body's own struct
Public Health & Prevention April 12,2024
New COVID-19 strategy: Vaccinate potential superspreaders first

New COVID-19 strategy: Vaccinate potential superspreaders first

by Macquarie UniversityCredit: Pixabay/CC0 Public DomainWith thousands of scientists around the world racing to develop a vaccine for COVID-19, policy makers may need to decide who is at the fron
Public Health & Prevention April 12,2024
New COVID-19 strategy: Vaccinate potential superspreaders first

New COVID-19 strategy: Vaccinate potential superspreaders first

by Macquarie UniversityCredit: Pixabay/CC0 Public DomainWith thousands of scientists around the world racing to develop a vaccine for COVID-19, policy makers may need to decide who is at the fron
Public Health & Prevention April 12,2024
CRISPR reveals the secret life of antimicrobial peptides

CRISPR reveals the secret life of antimicrobial peptides

by Ecole Polytechnique Federale de LausanneFruit flies with mutated antimicrobial peptides (red eyes) let bacteria (green fluorescence) grow out of control, while wild-type flies (with normal ant
Immunology & Rheumatology April 12,2024
CRISPR reveals the secret life of antimicrobial peptides

CRISPR reveals the secret life of antimicrobial peptides

by Ecole Polytechnique Federale de LausanneFruit flies with mutated antimicrobial peptides (red eyes) let bacteria (green fluorescence) grow out of control, while wild-type flies (with normal ant
Immunology & Rheumatology April 12,2024
Antibody production in patients hospitalized with COVID-19

Antibody production in patients hospitalized with COVID-19

by Mary Ann Liebert, IncCredit: Mary Ann Liebert, Inc., publishersAntibody-secreting cells (ASCs) peaked at 3-4 weeks and were still being produced at 3-4 months in patients hospitalized with COV
Public Health & Prevention April 12,2024
Antibody production in patients hospitalized with COVID-19

Antibody production in patients hospitalized with COVID-19

by Mary Ann Liebert, IncCredit: Mary Ann Liebert, Inc., publishersAntibody-secreting cells (ASCs) peaked at 3-4 weeks and were still being produced at 3-4 months in patients hospitalized with COV
Public Health & Prevention April 12,2024
How COVID-19 alters the immune system

How COVID-19 alters the immune system

by Ludwig Maximilian University of MunichDendritic cell. Credit: D. DudziakCOVID-19 reduces the numbers and functional competence of certain types of immune cells in the blood, say LMU researcher
Public Health & Prevention April 12,2024
How COVID-19 alters the immune system

How COVID-19 alters the immune system

by Ludwig Maximilian University of MunichDendritic cell. Credit: D. DudziakCOVID-19 reduces the numbers and functional competence of certain types of immune cells in the blood, say LMU researcher
Public Health & Prevention April 12,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com